GB1196594A — Improvements in and relating to the production of Sebacic Acid
Assigned to Geigy Co Ltd · Expires 1970-07-01 · 56y expired
What this patent protects
1,196,594. Production of sebacic acid. GEIGY (U.K.) Ltd. 23 Nov., 1967 [21 Dec., 1966], No. 52602/66. Heading C2C. Sebacic acid is prepared by hydrogenating 5-ketosebacic acid or 5-hydroxysebacic acid, or an alkali metal salt of either, with molecular hydrogen at a temperature ab…
USPTO Abstract
1,196,594. Production of sebacic acid. GEIGY (U.K.) Ltd. 23 Nov., 1967 [21 Dec., 1966], No. 52602/66. Heading C2C. Sebacic acid is prepared by hydrogenating 5-ketosebacic acid or 5-hydroxysebacic acid, or an alkali metal salt of either, with molecular hydrogen at a temperature above 200‹ C., in the presence of a hydrogenation catalyst of palladium or platinum. The hydrogenation may be effected in aqueous solution at a superatmospheric pressure for a period of from 4 to 8 hours.
Drugs covered by this patent
- Nexletol (BEMPEDOIC ACID) · Esperion Theraps Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.